Foresite Capital Management V
Major shareholder at Latigo Biotherapeutics · 8 reported transactions in 1 company · latest trade Aug 10, 2026
Their record
No purchases old enough to measure yet.
Their trades
Bought | Aug 10, 2026 | Aug 10, 2026 close $18.56 → Oct 30, 2026 close $13.95. S&P 500 −2.2% over the same days. |
BoughtLatigo Biotherapeutics
$2.52M
Aug 10, 2026 close $18.56 → Oct 30, 2026 close $13.95. S&P 500 −2.2% over the same days.